| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Zhou,Jin-Wen | Chairman | 6.50% | |
| Cai,Jin-Shan | Director | 6.27% | |
| Gao,Ming-Chuan | Director | 5.13% | |
| Zhong,Yan-Yan | Director | 6.77% | |
| Zhou,Zai-Fa | Independent Director | 0.01% | |
| Chen,Guang-Hong | Independent Director | 0.00% | |
| Liu,Xue-Li | Independent Director | 0.00% |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 543,824 | 2,236,740 | 2,126,487 |
| Operating cost | 303,257 | 1,165,733 | 1,220,249 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 240,567 | 1,071,007 | 906,238 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 240,567 | 1,071,007 | 906,238 |
| Operating expenses | 96,522 | 449,570 | 370,988 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 144,045 | 621,437 | 535,250 |
| Non-operating income and expenses | 44,338 | 207,983 | 144,323 |
| Net profit (loss) before tax | 188,383 | 829,420 | 679,573 |
| Income tax expense (benefits) | 34,795 | 162,531 | 141,079 |
| Net profit (loss) of ongoing business for the current period | 153,588 | 666,889 | 538,494 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 153,588 | 666,889 | 538,494 |
| Other comprehensive profit (loss), net | 17,272 | 46,448 | -5,030 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 170,860 | 713,337 | 533,464 |
| Net profit (loss) attributable to owners of parent company | 153,682 | 666,019 | 541,605 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | -94 | 870 | -3,111 |
| Comprehensive profit (loss) attributable to owners of parent company | 170,954 | 712,437 | 536,553 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | -94 | 900 | -3,089 |
| Basic earnings per share (yuan) | 1 | 4 | 3 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 170,181 | 850,944 | 848,184 |
| Net cash inflows (outflows) from investing activities | 29,930 | -196,961 | -13,076 |
| Net cash inflow (outflow) from financing activities | -12,915 | -508,919 | -587,883 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 10,600 | 23,952 | -2,580 |
| Increase (decrease) in cash and cash equivalents in the current period | 197,796 | 169,016 | 244,645 |
| Beginning balance of cash and cash equivalents | 1,054,027 | 885,011 | 640,366 |
| Ending balance of cash and cash equivalents | 1,251,823 | 1,054,027 | 885,011 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 2,433,873 | 2,304,842 | 1,987,843 |
| Non-current asset | 3,364,456 | 3,365,285 | 3,392,315 |
| Total asset | 5,798,329 | 5,670,127 | 5,380,158 |
| Current liability | 639,887 | 669,672 | 585,535 |
| Non-current liability | 1,037,227 | 1,050,100 | 1,099,659 |
| Total liability | 1,677,114 | 1,719,772 | 1,685,194 |
| share capital | 1,526,487 | 1,526,487 | 1,526,487 |
| Equity - secruity token | - | - | - |
| capital reserve | 135,562 | 135,562 | 135,562 |
| retained earning | 2,397,529 | 2,243,847 | 2,030,759 |
| Other equity | 30,447 | 13,175 | -28,228 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 4,090,025 | 3,919,071 | 3,664,580 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 31,190 | 31,284 | 30,384 |
| Total Equity | 4,121,215 | 3,950,355 | 3,694,964 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 26 | 25 | 24 |
Return deposit
2009
Stop execution
2010, 2024
Pay service fee
2013, 2014
Debtor objection appeal
2024
Pay severance pay, etc.
2020
Determine legal expenses
2009
Commercial Arbitration Enforcement Ruling
2009
Others
2001, 2002, 2003, 2004, 2005, 2006, 2007, 2009, 2010
Embezzlement
2024
Payment order
2014, 2020
Return deposit
2009, 2010
Stop execution
2009, 2010
Pay service fee
2014
New patent filing
2008
Waste Disposal Act
2009
Motion of objection
2009, 2010
Invalidating Judgment
2007
Provisional attachment
2009
Repay security deposit
2011
Invention patent filing
2016, 2017
Supplementary ruling fees
2024
Invalidating Judgment (Note)
2012, 2014
Compensation for damage, etc.
2010
Infringement damage compensation
2007, 2008, 2009
Petition filed for public summons
2012, 2013
Revocation of Arbitration Judgment
2009, 2010
Commercial Arbitration Enforcement Ruling
2010
